Adjuvant chemotherapy Archives - Inside Precision Medicine

Inside Precision Medicine New Data Confirm PARP Inhibitor’s Efficacy in HER2-Negative, BRCA-Positive Breast Cancer

Dividing breast cancer cell, PARP Inhibitor

News & Features

New Data Confirm PARP Inhibitor’s Efficacy in HER2-Negative, BRCA-Positive Breast Cancer

December 11, 2024

College of two photomicrograph showing Invasive ductal carcinoma (IDC) grade-II, most common form of breast cancer. Lymphovascular invasion: Present

News & Features

Extended Estrogen Suppression Safe in Breast Cancer

September 20, 2024

Dividing breast cancer cell, PARP Inhibitor

Molecular Dx

Commonly Ordered Breast Cancer Biomarker Test May Result in Bad Recommendations for Black Women

January 31, 2024

Micrograph of Renal Cell Carcinoma (RCC)

Molecular Dx

12-Gene Panel May Identify Recurrence Risk in Patients with RCC

Laura Cowen

March 1, 2023

Lung cancer cells, SEM

Molecular Dx

Firepower and Focus: OncoCyte Launches NSCLC Stratification, Broadens Dx Offerings

January 24, 2020

Related Content

New AI-Based Tool Better Matches Patients to Cancer Trials

New AI-Based Tool Better Matches Patients to Cancer Trials

Tongue Cancer Organoids Reveal Key Pathways for Overcoming Drug Resistance

Tongue Cancer Organoids Reveal Key Pathways for Overcoming Drug Resistance

New Test Predicts Survival in Early-Stage Lung Cancer Better than Current Methods

New Test Predicts Survival in Early-Stage Lung Cancer Better than Current Methods

Topical Therapy Trains Immune System to Eliminate Precancerous Skin Lesions

Topical Therapy Trains Immune System to Eliminate Precancerous Skin Lesions